Kitov Pharma's arthritis drug meets main goal in late-stage study

(Reuters) - Kitov Pharmaceuticals Holdings Ltd said on Tuesday its lead drug met the main goal of a late-stage study, reducing pain without increasing the risk of heart diseases in patients with a type of arthritis.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro